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A heterozygous mutation in the Langerin gene corresponding to position 837 in the Langerin mRNA was identiﬁed
in a person deﬁcient in Birbeck granules (BG). This mutation results in an amino acid replacement of tryptophan by
arginine at position 264 in the carbohydrate recognition domain of the Langerine protein. Expression of mutated
Langerin in human ﬁbroblasts induces tubular-like structures that are negative for BG-specific antibodies and do
not resemble the characteristic structural features of BG.
Key words: mutation PCR/expression/GFP fusion protein/nucleofection/immunoelectron microscopy/heterozygosity
J Invest Dermatol 124:714 –717, 2005
Birbeck granules (BG) are cytoplasmic organelles that are
only found in Langerhans cells (LC). The function of BG, first
described in 1961 (Birbeck et al, 1961), is still not com-
pletely understood, although most studies point toward an
active role in receptor-mediated endocytosis and participa-
tion in the antigen-processing/presenting function of LC (Mc
Dermott et al, 2002). Recent studies demonstrated a crucial
role for the C-type lectin Langerin, in the biogenesis of BG.
Expression of human or mouse cDNA encoding Langerin,
an endocytic receptor exclusively present in LC, into fibro-
blasts results in the formation of BG (Valladeau et al, 2000,
2002).
About 10 y ago, we were the group that identified a
healthy white man whose LC completely lack the presence
of BG as determined by electron microscopic studies (Mo-
mmaas et al, 1994). The absence of BG in these LC was
documented further by the lack of staining with a BG-spe-
cific antibody (DCGM4). Considering the role of Langerin in
the formation of BG and the fact that DCGM4 recognizes
Langerin (Valladeau et al, 1999), we hypothesized that al-
terations/mutations in the Langerin gene might be respon-
sible for the lack of BG in this index person.
To test this hypothesis, we performed DNA sequence
analysis of all Langerin-encoding exons from the index per-
son lacking BG. We identified a hitherto unknown mutation
resulting in an amino acid substitution (W4R) at position
264 in a conserved (carbohydrate recognition) domain of
the Langerin protein. Expression of a wild-type Langerin
construct in dermal fibroblast resulted in BG positive for
DCGM4. Expression of the mutant Langerin construct,
identical to wild-type except for the single base pair sub-
stitution, resulted in irregular tubular structures, negative for
DCGM4. From these data, we conclude that W264 in the
Langerin protein is essential for BG biogenesis.
Results and Discussion
PCR and sequence analysis of Langerin encoding ex-
ons PCR analysis of all Langerin encoding exons demon-
strated no large differences in terms of deletions/insertions
between the DNA of the index person and the control DNA
(Fig 1A). DNA sequence analysis of all obtained PCR prod-
ucts revealed that the exons encoding Langerin in our index
person were heterozygous at four positions: 281, 837, 880,
and 989. Two of these mutations were silent (position 281 C/
T and 989 A/G), whereas the other two resulted in an amino
acid change in the Langerin protein (Fig 1B). Heterozygosity
at position 880, however, was also found in the control DNA
(see Fig 1B, right panel) and in the cDNA of the second
control that was used as a basis to create the Langerin
expression constructs. Moreover, until recently, this nuc-
leotide was indicated as a known single nucleotide poly-
morphism in Genbank; this annotation was removed after a
recent update (July 2004). Heterozygosity at position 837 is
of particular interest because it encodes a variant Langerin
containing the basic residue arginine (R) instead of the ar-
omatic amino acid tryptophan (W) in a highly conserved
region of the Langerin protein and related type II C-type
lectins (Fig 1C). As this mutation was located in the carbo-
hydrate recognition domain, we reasoned that this mutation
(W264R) might have functional consequences for the
Langerin protein.
Expression of wild-type and mutant Langerin cDNA Ex-
pression of wild-type Langerin with or without green fluo-
rescent protein (GFP) in human fibroblasts resulted in the
Abbreviations: BG, Birbeck granules; GFP, green fluorescent pro-
tein; LC, Langerhans cells
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mass formation of BG, as was revealed by transmission
electron microscopy (Fig 2), indicating that GFP did not in-
terfere with the formation of BG. BG in GFP-wild-type La-
ngerin-transfected cells were strongly positive for anti-GFP
(Fig 3A) and moderate positive for DCGM4-labeling (Fig 3B).
In contrast, expression of GFP-mutant Langerin did not in-
duce the formation of BG, demonstrating the functional
consequences of the W264R conversion. Although lacking
BG, transfection of human fibroblasts with the GFP-mutant
Langerin induced the formation of an assembly of GFP-
positive tubular membrane structures seemingly consisting
of lipid bilayers, but lacking the organization found in BG
(Fig 3C). The membrane structures induced by the mutant
Langerin were negative for DCGM4 labeling, although ex-
pression of the protein was confirmed by staining for GFP.
These results suggest that the W264R mutation is either
located in the epitope recognized by DCGM4 or that it
causes a conformational change preventing the binding of
the antibody. Furthermore, these data demonstrate that the
W264R amino acid replacement prevents the formation of
the regular-shaped BG. Nonetheless, this mutant Langerin
is still able to induce the formation of lipid bilayer membrane
structures. The mechanisms by which this mutation pre-
vents the formation of the superimposed and zippered
membranes typical for BG are currently under investigation
and will expand our understanding of the role of Langerin in
the formation of BG and in the function of Langerin and BG
in LC.
Materials and Methods
This study was conducted according to the Declaration of Helsinki
Principles and was approved (where applicable) by the medical
ethical committee of the LUMC.
PCR All PCR were carried out using custom primers and Platinum
Taq from Invitrogen (Breda, the Netherlands) in a PTC-200 Thermal
cycler (MJ Research, Waltham, Massachusetts).
Sequencing of the Langerin gene DNA was isolated from pe-
ripheral blood lymphocytes of the index person lacking BG (Mo-
mmaas et al, 1994) and controls (all obtained with written informed
consent) using the QIAamp DNA mini kit (Qiagen, Hilden, Germa-
ny). Individual Langerin-encoding exons were amplified by PCR
(touchdown protocol, annealing temperature 651C–501C over 15
cycli followed by 20 cycli at 501C) using six primer sets (See Table I)
developed on the human DNA and mRNA sequences deposited in
the Genbank under #AC007395 and NM_015717. PCR products
were purified and directly sequenced from both 50 and 30 ends
using an ABI 3700 automatic sequencer (Applied Biosystems,
Foster City, California).
Heterologous expression of mutant and wild-type Langerin
cDNA In default of a frozen skin biopsy from the index person
enabling mRNA extraction, wild-type and mutant Langerin expres-
sion constructs were created as follows. cDNA synthesized from
mRNA isolated from normal skin (obtained from plastic surgery
with written informed consent from the donor) was used as a tem-
plate for a Langerin-specific PCR (Primers S1/AS1, see Table I;
annealing at 501C; 35 cycli). The resulting 1049 bp PCR product
was cloned in pTOPO (Invitrogen) and sequenced. The identified
Figure 1
Analysis of the Langerin gene. (A) Representative example of a PCR analysis using Langerin-specific primers for exons 1–6 and as template
genomic DNA of the index person lacking Birbeck granules (BG) (a), control DNA (b), or no template (c). Obtained PCR products were analyzed on a
TBE-based agarose gel and stained with ethidium bromide. M denotes DNA marker (Generuler 100 bp ladder; Fermentas, St Leon-Rot, Germany);
size in base pairs is given on the left. (B) Fragment of a sequence chromatogram of a PCR product representing exon 5 of the index person lacking
BG. A double sequence (T/C) is detected at positions 837 and 880. Corresponding amino acids are given on top using single letter abbreviation. (C)
Alignment of a conserved domain within the type II C-type lectin family of proteins. Arrow indicates conserved tryptophan residue (W) at position 264
within this family.
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mutation at position 837 (numbering according to NM_015717)
was introduced in the Langerin cDNA sequence by overlap exten-
sion mutation PCR (Horton et al, 1990) using two mutation primers
(See Table I) in combination with the S1/AS1 primers at the 50 and
30 end and the pTOPO plasmid containing wild-type Langerin
cDNA as template. PCR products were cloned in pTOPO and se-
quenced.
Next, the coding regions of both the wild-type and mutant La-
ngerin cDNA were amplified with PCR primers containing flanking
sequences for Gateway cloning and pTOPO (harboring wild-type
Figure 2
Detection of Birbeck granules (BG) in Langerin expressing fibroblasts by electron microscopy. Human fibroblasts transfected with wild-type
Langerin (A) or wild-type green fluorescent protein (GFP)-Langerin (B) show typical structures reminiscent of BG. Scale bar¼ 150 nm.
Figure 3
Immuno-electron microscopic analysis of green fluorescent protein (GFP)-Langerin expressing fibroblasts. (A, B) Typical anti-GFP (A) or
DCGM4 (B) immunostaining of fibroblasts transfected with GFP-wild-type Langerin construct. (C) Representative example of an anti-GFP staining of
fibroblasts transfected with GFP-mutant Langerin construct. Antibodies were detected with 15 nm protein A-gold. Scale bar¼150 nm.
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or mutant sequences) as template. The resulting PCR products
were cloned in the Gateway Cloning vectors (Invitrogen) pDEST53,
linking GFP to the N-terminus of Langerin, and pDEST 12.2. All
Gateway constructs were sequenced to confirm the position of the
insert and the absence of PCR errors.
Human primary dermal fibroblasts (cultured in DMEM, supple-
mented with L-glutamine (2 mM, Gibco BRL, Breda, the Nether-
lands), 5% FCS (Hyclone/Perbio, Etten Leur, the Netherlands), and
penicillin/streptomycin (Gibco BRL) were transfected with Gateway
constructs containing the wild-type or mutant Langerin cDNA us-
ing the Amaxa nucleofector (Amaxa, Cologne, Germany). The
transfections were performed according to the Human Dermal fib-
roblast Nucleofector Kit (Amaxa) and protocol. The cells were cul-
tured for a maximum of 40 h in a 371C/5% CO2 incubator and
prepared for electron microscopy.
Electron microscopy For electron microscopy, cells were fixed in
2% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M PHEM
buffer for 2 h at room temperature. Part of the cells were processed
further for routine electron microscopy and the other part for
immuno-electron microscopy. For routine electron microscopy,
cells were post-fixed in 1% osmiumtetroxide in 0.1 M phosphate
buffer for 30 min at 41C, dehydrated in a graded ethanol series, and
embedded in epon LX112. Ultrathin sections were stained with
uranylacetate and lead salts. For immuno-electron microscopy,
cells were pelleted in 12% gelatin, cryoprotected in 2.3 M sucrose,
and snap-frozen in liquid nitrogen. Ultrathin cryosections were
incubated with either mouse monoclonal anti-Langerin IgG1
(formerly known as DCGM4; Beckman Coulter, Mijdrecht, the
Netherlands) (1/100), followed by a rabbit anti-mouse immuno-
globulins as bridging antibody (DAKOcytomation, Heverlee, Bel-
gium) (1/200) and 15 nm protein A-gold (1/200) or rabbit polyclonal
anti-GFP IgG (Molecular Probes Europe, Leiden, the Netherlands)
(1/200) followed by 15 nm protein A-gold. After incubation, the
sections were embedded in methylcellulose and stained with ur-
anylacetate. All specimens were viewed with a Philips 410 electron
microscope (Philips, Eindhoven, the Netherlands).
The authors thank Jos Onderwater for help with the immuno-electron
microscopy.
DOI: 10.1111/j.0022-202X.2005.23645.x
Manuscript received July 19, 2004; revised September 15, 2004;
accepted for publication November 5, 2004
Address correspondence to: Cornelis P. Tensen, Department of Der-
matology, Leiden University Medical Center, Wassenaarseweg 72,
2333 AL Leiden, The Netherlands. Email: cp.tensen@lumc.nl
References
Birbeck MS, Breathnach AS, Everall JD: An electron microscope study of basal
melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J
Invest Dermatol 37:51–63, 1961
Horton RM, Cai ZL, Ho SN, Pease LR: Gene splicing by overlap extension: Tailor-
made genes using the polymerase chain reaction. Biotechniques 8:
528–535, 1990
Mc Dermott R, Ziylan U, Spehner D, et al: Birbeck granules are subdomains of
endosomal recycling compartment in human epidermal Langerhans cells,
which form where Langerin accumulates. Mol Biol Cell 13:317–335, 2002
Mommaas M, Mulder A, Vermeer BJ, Koning F: Functional human epidermal
Langerhans cells that lack Birbeck granules. J Invest Dermatol 103:
807–810, 1994
Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, et al: Identification of
mouse langerin/CD207 in Langerhans cells and some dendritic cells of
lymphoid tissues. J Immunol 168:782–792, 2002
Valladeau J, Duvert-Frances V, Pin JJ, et al: The monoclonal antibody DCGM4
recognizes Langerin, a protein specific of Langerhans cells, and is rapidly
internalized from the cell surface. Eur J Immunol 29:2695–2704, 1999
Valladeau J, Ravel O, Dezutter-Dambuyant C, et al: Langerin, a novel C-type
lectin specific to Langerhans cells, is an endocytic receptor that induces
the formation of Birbeck granules. Immunity 12:71–81, 2000
Table I. PCR primers used in this studya
Langerin
target Primer sequence (50430)
Product
size (bp)
Exon 1 S TGGGATAGGTTTGGGACAAG 405
AS GTGTGTTGAAGGAGCAGCAA
Exon 2 S TTGCTGCTCCTTCAACACAC 191
AS GCTAAGCCCAGACGATGAAA
Exon 3 S CCTCAGCTGACCTCCTGACT 479
AS CCTCAGGTCTGGGACAGGTA
Exon 4 S CCAGCGTTCACTTTTACCTCTT 222
AS ATACGCCCCCTTCACAGAG
Exon 5 S CGCACCTCTGCTTATCCTGT 242
AS CCTGTCTCATGGGGAACATC
Exon 6 S GGACAAAAGCTTGGGTTGAG 1123
AS CCTGGACAACCAGAAATGAAA




GWS1 GGG GAC AAG TTT GTA CAA
AAA AGC AGG CTT CAG GAT
GAC TGT GGA GAA GGA
1051
GWAS1 GGG GAC CAC TTT GTA CAA
GAA AGC TGG GTG TCA CGG












aPositions of mutations in MUT AS1 and MUT S1 are underlined.
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